A century of the synthesis of dapsone: Its anti-infective capacity now and then

International Journal of Dermatology

Volumn 39, Issue 10, 2000, Pages 779-783

  Wolf, R ^a   Orni Wasserlauf, R ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DAPSONE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; DRUG EFFICACY; DRUG SCREENING; DRUG SYNTHESIS; ESCHERICHIA COLI; INFLAMMATORY DISEASE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

DAPSONE; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

EID: 0033765817     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2000.00739.x     Document Type: Article

References (83)

1. Sulfone therapy of leprosy. Background, early history and present status
2. The story of sulfones in tropical medicine and dermatology
3. Leprosy today
4. New approaches to chemotherapy for leprosy
5. The antimalarial and hemolytic properties of 4,4'-diaminodiphenylsulfone (DDS)
6. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus
7. Dapsone, trimethoprim and sulfamethoxazole plasma levels during treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome (AIDS). Evidence of drug interactions
8. Dermatitis herpetiformis and linear IgA bullous dermatosis
9. Treatment and management of dermatitis herpetiformis
10. The treatment of dermatitis herpetiformis
11. Treatment of bullous pemphigoid with dapsone: Retrospective study of thirty-six cases
12. Dapsone as the first line treatment for bullous pemphigoid
13. Dapsone for the treatment of bullous pemphigoid
14. Systemic chemotherapy for ocular cicatricial pemphigoid
15. Dapsone therapy of cicatricial pemphigoid
16. Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone
17. Chronic bullous disease of childhood
18. Chronic bullous disease of childhood - Aspects of management
19. Bullous disease of childhood
20. Epidermolysis bullosa acquisita in childhood
21. Childhood epidermolysis bullosa acquisita
22. Childhood epidermolysis bullosa acquisita. Report of three cases and review of literature
23. Sulfapyridine and sulfone type drugs in dermatology
24. Pyoderma gangrenosum treated with sulfone drugs
25. Diaminodiphenylsulfone and steroids in the treatment of pyoderma gangrenosum
26. Subcorneal pustular dermatosis
27. Intraepidermal neutrophilic IgA dermatosis
28. Subcorneal pustular dermatosis associated with rheumatoid arthritis and raised IgA: Simultaneous remission of skin and joint involvements with dapsone treatment
29. Acropustulosis of infancy
30. Infantile acropustulosis
31. Pustular psoriasis
32. Pustular psoriasis of the erythema annulare centrifugum type. Treatment with disulfone
33. Atypical pustular psoriasis treated with dapsone
34. Purpuras and related conditions
35. Current therapies for systemic vasculitis
36. Sulfone therapy in the treatment of leukocytoclastic vasculitis. Report of three cases
37. Erythema elevatum diutinum in human deficiency virus-infected-patients - Report of a case and review of the literature
38. Erythema elevatum diutinum: A clinicopathological study
39. Erythema elevatum diutinum: Skin and systemic manifestations, immunologic studies and successful treatment with dapsone
40. A comparison of dapsone with 13-cis retinoic acid in the treatment of nodular cystic acne
41. Experience with disulfone in the treatment of severe nodular acne
42. How I treat acne
43. Relapsing polychondritis
44. Treatment of relapsing polychondritis with dapsone
45. Relapsing polychondritis treated with dapsone
46. Treatment of cutaneous lesions in patients with lupus erythematosus
47. Dapsone in cutaneous lesions of SLE: An open study
48. Dapsone in the treatment of cutaneous lupus erythematosus
49. Dapsone treatment of a brown recluse bite
50. Spider bites. Review in depth
51. Spiders and spider bites
52. Suppression of Behcet's disease with dapsone
53. Treatment of Behcet's disease with dapsone
54. Behcet's disease in South African blacks: Report of five cases
55. The response of generalized granuloma annulare to dapsone
56. Sulfone treatment of granuloma annulare
57. Treatment of generalized granuloma annulare with dapsone
58. Dapsone in the treatment of Kaposi's sarcoma
59. Changes in Kaposi's sarcoma induced by dapsone
60. Non-HIV-related Kaposi's sarcoma suppressed by dapsone
61. Recurrent nodular panniculitis in alpha-1-antitrypsin deficiency. Successful dapsone therapy
62. Alpha-1-antitrypsin deficiency-associated panniculitis: Case report and review of the literature
63. Alpha-1-antitrypsin deficiency and panniculitis. Perspectives on disease relationship and replacement therapy
64. Childhood lichen planus
65. Treatment of erosive lichen planus with dapsone
66. Dapsone in the treatment of erosive lichen planus
67. Recurrent erythema multiforme: Clinical features and treatment in a large series of patients
68. Continuous erythema multiforme clearing on dapsone
69. Febrile ulceronecrotic Mucha-Habermann's disease and its successful therapy with DDS
70. Histiocytic medullary reticulosis presenting as Mucha-Habermann disease
71. Ofuji's disease with unusual histological features
72. The spectrum of inflammatory skin disease following jejuno-ileal bypass for morbid obesity
73. Dapsone in granulomatous rosacea
74. Treatment of pyoderma vegetans of Hallopeau with dapsone
75. Acroangiodermatitis: Review of the literature and report of a case
76. Ein Beitrag zur chemotherapie der bakteriellen Infektionen
77. Eine neue klasse von Desinfectionsmitteln
78. The treatment of streptococcal infections in mice with 4:4'diaminodiphenylsulfone
79. Action anti-streptococcique des derives fulfures organiques
80. Die chemotherapeutische Wirksamkeit des 4,4'-Diamonodiphenylsulfons und seiner Derivate
81. Note preliminaire sur l'action de la para-diacetyl-amonodiphenyl sulfone (1399F) dans la blennorrhagic
82. Observations concerning the toxicity, absorption and therapeutic effect of sulphanilamide and certain related organic sulphur-containing compounds in experimental infections in mice